Regulatory News
Monday, July 25, 2016
BRIEF-Allergan receives positive opinion for its treatment for IBS-D in adults
* Allergan receives positive opinion for Truberzi
(eluxadoline) for treatment of irritable bowel syndrome with
diarrhoea (IBS-D) in adults
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment